Matinas BioPharma Holdings (MTNB) Non-Current Assets (2013 - 2026)
Matinas BioPharma Holdings' Non-Current Assets was $2.27 million in Q2 2026, down 45.4% from $4.16 million a year earlier and down 25.8% from the prior quarter.
Powered by 
Analysis
Matinas BioPharma Holdings (MTNB) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Non-Current Assets at Matinas BioPharma Holdings came in at $3.13 million, down 32.1% from FY2024.
- Non-Current Assets has now declined for four consecutive years, with a five-year compound annual growth rate of -19.7% (FY2020 to FY2025).
- In earlier years, Non-Current Assets was $4.62 million in FY2024 (-51.7%), $9.56 million in FY2023 (-7.1%), $10.29 million in FY2022 (-0.4%) and $10.33 million in FY2021 (+9.8%).
- The Q2 2026 figure marks the lowest quarterly Non-Current Assets since Q3 2018.
- Compared with a year earlier, Non-Current Assets has declined for 16 straight quarters, with an average decline of 41.4% over the last eight quarters.
- The best year-over-year quarter for Non-Current Assets over five years was Q2 2022 (growth of 16.2%); the worst was Q3 2025 (a decline of 54.3%).
- Per Business Quant data, MTNB's Non-Current Assets in the three quarters before Q2 2026 was $3.06 million (Q1 2026), $3.13 million (Q4 2025) and $4.04 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Matinas BioPharma Holdings | 16.27 Mn | 3.68 Mn | - | 2.27 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.27 Mn |
| Mar 31, 2026 | 3.06 Mn |
| Dec 31, 2025 | 3.13 Mn |
| Sep 30, 2025 | 4.04 Mn |
| Jun 30, 2025 | 4.16 Mn |
| Mar 31, 2025 | 4.49 Mn |
| Dec 31, 2024 | 4.62 Mn |
| Sep 30, 2024 | 8.84 Mn |
| Jun 30, 2024 | 9.08 Mn |
| Mar 31, 2024 | 9.32 Mn |
| Dec 31, 2023 | 9.56 Mn |
| Sep 30, 2023 | 9.80 Mn |
| Jun 30, 2023 | 10.03 Mn |
| Mar 31, 2023 | 10.06 Mn |
| Dec 31, 2022 | 10.29 Mn |
| Sep 30, 2022 | 10.45 Mn |
| Jun 30, 2022 | 10.49 Mn |
| Mar 31, 2022 | 10.67 Mn |
| Dec 31, 2021 | 10.33 Mn |
| Sep 30, 2021 | 10.50 Mn |
API Access
Matinas BioPharma Holdings Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=MTNB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "MTNB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=MTNB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();